New York City, NY -- (SBWIRE) -- 01/28/2014 -- To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
StockMarketIntel.com issues a special report on the following stocks: The Dolan Company (NYSE:DM), BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), Geron Corporation (NASDAQ:GERN), ChinaCache Internatnl Hldgs Ltd (ADR) (NASDAQ:CCIH)
The Dolan Company (NYSE:DM) declined -16.22%, trading on 1.63 million shares, to end the trade at $0.310. The stock changed hands in a range of $0.31 to $0.41, bringing its market capitalization to about $9.57 million. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.31 and was moved to the maximum level of $3.65. The Dolan Company is a provider of necessary professional services and business information to legal, financial and real estate sectors in the United States. The Company operates through two operating divisions: its Professional Services Division and its Business Information Division.
Will DM Get Buyers Even After The Recent Rally? Find Out Here
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) declined -15.43%, to complete the trading session at $9.81, with a total volume of 3.68 million shares. The stock, on average, trades on a volume of 1.37 million shares. It floated in a range of $9.15 to $10.99 during the last trading session, with a beta value of 3.03. Its market capitalization now moved to about $579.69 million. In the past 52 weeks, the share price has not declined below $1.12 and above $12.35. BioCryst Pharmaceuticals, Inc. (BioCryst) is a biotechnology company. BioCryst designs, optimizes and develops drugs that block enzymes involved in the pathogenesis of diseases. The Company focuses on therapeutic areas. Peramivir is its product, which is a neuraminidase inhibitor for the treatment of patients with influenza.
Will BCRX Bounce Back After yesterday’s Sharp Sell off? Find Out Here
Geron Corporation (NASDAQ:GERN) recorded a fall of -15.30% and was in a range of $4.50-$5.15 before closing at $4.76. The stock completed the day with a total volume of 11.15 million shares, versus an average volume of 4.74 million shares. The share price hit its 52-week low of $0.98 and $7.79 was the best price. Geron Corporation (Geron) is a clinical-stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. Telomerase is an enzyme that enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication. Imetelstat is a specific inhibitor of telomerase.
Will GERN Bounce Back After yesterday’s Sharp Sell off? Find Out Here
ChinaCache Internatnl Hldgs Ltd (ADR) (NASDAQ:CCIH) declined -14.48% yesterday, bringing its market capitalization around $324.85 million. The share price, after opening at $16.11, made a high of $16.42 and hovered above $12.90 to end the day at $13.88. The total number of shares that changed hands during the session was 1.41 million shares, as compared to average trading volume of 755,618 shares. ChinaCache International Holdings Ltd. (ChinaCache) is a holding company. The Company is engaged in the provision of Internet content and application delivery total solutions in China. The Company provides a portfolio of services and solutions to businesses, government agencies and other enterprises to enhance the reliability and scalability of their online services and applications and improve end-user experience.
Will CCIH Reach the Bottom after Yesterday’s Correction? Find Out Here
To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)